Genus PLC PIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
28 Junho 2021 - 1:00PM
RNS Non-Regulatory
TIDMGNS
Genus PLC
28 June 2021
For Immediate Release
28 June 2021
Genus plc
('Genus', or the 'Company')
PIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
Genus plc (LSE: GNS), a leading global animal genetics company,
announces that its porcine genetics business, PIC, has entered into
a strategic relationship with the shareholders of Sergal Gestió
Ramadera, S.L., a leading Spanish porcine genetic distributor. The
relationship will become effective in the third quarter of
2021.
Sergal is a leading porcine distributor in Spain and its high
quality supply chain, commitment to customer service and innovative
culture make it an ideal partner to enhance the distribution of
PIC's elite porcine genetics in the Spanish and European markets.
This strategic relationship will support pork producers across
Europe by combining PIC's elite genetics with Sergal's focus on
customer service and deep knowledge of the market. The commercial
terms of the relationship remain confidential.
Under the strategic relationship, PIC will acquire Sergal's
semen supply chain, which will be integrated into PIC's European
gene transfer network, and certain other commercial assets. The
parties will continue to collaborate to ensure an ongoing focus on
customer service and the delivery of PIC's elite genetics and
related services.
Within the EU, the pig herd in Spain continues to expand year on
year due to strong domestic demand and a focus on exports. Spain
continues to be one of the key global pork markets exporting to
China.
Commenting on the strategic relationship, Albert Noguera and
Sergi Armengol - Sergal's founders and owners - said: "When we
created the company our vision was to provide the best genetics to
Spanish producers. This new relationship with PIC will help us
further expand our offering and services and to realize our
vision."
Jürgen Kramer, General Manager for PIC Europe added: "Spain is a
key market in global pig production with tremendous opportunity for
growth. This strategic relationship represents a further milestone
in PIC's European strategy, where we continue to make significant
investments given the long-term potential of the region."
Genus Tel: +44 (0)1256
347100
Stephen Wilson, Chief Executive
Alison Henriksen, Chief Financial
Officer
Buchanan Tel: +44 (0)207
466 5000
Charles Ryland /Chris Lane
About Genus
Genus is a world-leading animal genetics company. Genus creates
advances to animal breeding and genetic improvement by applying
biotechnology and sells added value products for livestock farming
and food producers. Its technology is applicable across livestock
species and is currently commercialised by Genus in the dairy, beef
and pork food production sectors.
Genus's worldwide sales are made in over seventy-five countries
under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs)
and comprise semen, embryos and breeding animals with superior
genetics to those animals currently in farms. Genus's customers'
animals produce offspring with greater production efficiency, and
quality, and use these to supply the global dairy and meat supply
chains.
The Group's competitive edge has been created from the ownership
and control of proprietary lines of breeding animals, the
biotechnology used to improve them and its global supply chain,
technical service and sales and distribution network.
With headquarters in Basingstoke, United Kingdom, Genus
companies operate in over twenty-five countries on six continents,
with research laboratories located in Madison, Wisconsin, USA.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRASELFLAEFSEDM
(END) Dow Jones Newswires
June 28, 2021 12:00 ET (16:00 GMT)
Genus (LSE:GNS)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Genus (LSE:GNS)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024